Vaccines effective against severe disease, hospitalisation caused by Omicron: EMA

by IANS |

Brussels, Jan 12 (IANS) Citing preliminary data, the European Medicines Agency (EMA) has said that the Covid-19 vaccines remain effective against severe disease and hospitalisation caused by the Omicron coronavirus variant.

"Although Omicron appears to be more infectious than other variants, studies conducted in South Africa, the UK and some European Union (EU) member states show a lower risk of being hospitalised after infection with Omicron. Based on these studies, the risk is currently estimated to be between a third and half of the risk with the Delta variant," the EMA said on Tuesday in a release.

It cited results from recently published studies as showing that vaccine effectiveness against symptomatic disease is lower for Omicron than for other variants and tends to wane over time. As a result, more vaccinated people are likely to develop breakthrough disease due to Omicron.

However, these studies also show that vaccination continues to provide a high level of protection against severe disease and hospitalisation linked to the Omicron variant, Xinhua news agency reported.

The latest evidence, which includes real-world effectiveness data, also suggests that people who have had a booster dose are better protected than those who have only received their primary course.

The EMA's Head of Vaccines Strategy, Marco Cavaleri, said at a press conference on Tuesday that the agency continued to monitor the vaccines' effectiveness, and the outcome of this assessment may impact future vaccination strategies recommended by experts in the EU member states.

He added that having to take a booster dose every three or four months was not effective enough as a long-term strategy.

"We do not yet have data on the fourth dose to allow us to express ourselves, but we are concerned about a strategy that foresees going ahead with vaccinations in a short time," he said.

The EMA added in the statement that efforts should continue to increase full vaccination uptake in individuals who are currently unvaccinated or partially vaccinated and to accelerate the rollout of booster doses.

Latest News
Modi meets industry leaders in Japan, invites them to invest in India Mon, May 23, 2022, 04:30 PM
Vismaya suicide: Husband found guilty Mon, May 23, 2022, 04:20 PM
Karnataka syllabus revision row: Reviewing of PUC-II history book likely to create stir Mon, May 23, 2022, 04:16 PM
Experts warn of unusual monkeypox outbreak in Aus Mon, May 23, 2022, 04:02 PM
HSBC suspends senior executive who said climate change is being exaggerated Mon, May 23, 2022, 03:56 PM
Debutants Titans face off against Rajasthan Royals in direct ticket to final Mon, May 23, 2022, 03:55 PM
Shadab, Nawaz return for Pakistan's ODI series against West Indies Mon, May 23, 2022, 03:52 PM
Heatwave, reduced wheat production credit negative for India: Moody's Mon, May 23, 2022, 03:46 PM
Rosneft commemorates oilmen feat in World War II Mon, May 23, 2022, 03:23 PM
Karnataka Cong MLA eats food removed from Dalit seer's mouth, video goes viral Mon, May 23, 2022, 03:17 PM
Night markets in Seoul set to reopen after 2 yrs Mon, May 23, 2022, 03:15 PM
WHO honours ASHA workers, PM delighted Mon, May 23, 2022, 03:12 PM
Covid, monkeypox poses formidable challenge to world: WHO Mon, May 23, 2022, 03:07 PM
BJP's tally in Bengal Assembly set to come down below 70 Mon, May 23, 2022, 03:06 PM
Khalistani OGWs asked to target goods trains in Punjab by ISI, Intel agencies warn Mon, May 23, 2022, 03:04 PM